Our share price is going to continue to follow the XBI (up or down) until A2-73 is approved for a disease...which I expect next year.
We should get a good bump when the TLR is announced for the EXCELLENCE Rett trial...which is due sometime in the next 3 - 4 months. After that, we should get some spikes in our SP along the way...but the BIG payoff is still 12 - 16 months away.